Investor/Media Information

2015 Press Releases

Keyword Search
 
2017 | 2016 | 2015

December 1, 2015: Abeona Therapeutics to Present at Piper Jaffray 27th Annual Healthcare Conference

November 18, 2015: Abeona Therapeutics to Present at Jefferies 2015 Global Healthcare Conference

November 17, 2015: Abeona Therapeutics Reports Financial Results and Highlights for Third Quarter 2015

October 6, 2015: Abeona Therapeutics Announces License for Next Generation AAV Delivery Vector for Fanconi Anemia and Rare Blood Disease Platform

October 1, 2015: Abeona Therapeutics to Present at 2015 Stem Cell Meeting on the Mesa

September 3, 2015: Abeona Therapeutics to Present at 2015 Rodman & Renshaw Annual Global Investment Conference

August 24, 2015: Abeona Therapeutics to Present at the 2015 Sidoti Emerging Growth Conference

August 17, 2015: Abeona Therapeutics Announces Recent Highlights and Second Quarter 2015 Conference Call

August 3, 2015: Abeona Therapeutics Announces Closing of Upsized $15.5 Million Equity Financing With Institutional Investors and Management

July 28, 2015: Abeona Therapeutics Announces $8.5 Million Equity Financing With Current Institutional Investors and Directors

July 7, 2015: Abeona Therapeutics Provides Update on SDF(TM) (Salt Diafiltration) Plasma Fractionation Products

July 1, 2015: Abeona Therapeutics Raises Additional $4.6 Million Through Warrant Exercises in Q2 15

June 22, 2015: Abeona Therapeutics Set to Join Russell Global, Russell 3000(R) and Russell MicroCap(R) Indexes

June 19, 2015: PlasmaTech Biopharmaceuticals Announces Name Change to Abeona Therapeutics to Reflect Broader Rare Disease Commitment

June 17, 2015: PlasmaTech Biopharmaceuticals to Present at the 2015 BIO International Convention

June 15, 2015: PlasmaTech Biopharmaceuticals Expands Rare Disease Pipeline With License Agreement for Gene Therapy in Fanconi Anemia & CRISPR/Cas9-Based Technology Platform for Rare Blood Disorders

June 8, 2015: PlasmaTech Biopharmaceuticals Announces License Agreement for AAV Gene Therapy to Treat Patients With Juvenile Batten Disease

June 1, 2015: PlasmaTech Biopharmaceuticals to Present at the 2015 Jefferies Healthcare Conference

May 29, 2015: PlasmaTech Biopharmaceuticals to Present at the 2015 LD Micro Invitational Conference

May 27, 2015: PlasmaTech Biopharmaceuticals to Present at the 2015 Marcum MicroCap Conference

May 26, 2015: REMINDER: PlasmaTech Biopharmaceuticals First Quarter 2015 Conference Call Tomorrow

May 20, 2015: PlasmaTech Biopharmaceuticals Announces Orphan Drug and Rare Pediatric Disease Designations From FDA

May 18, 2015: PlasmaTech Biopharmaceuticals Closes Abeona Therapeutics Acquisition

May 15, 2015: PlasmaTech Biopharmaceuticals Files First Quarter 2015 Financial Results and Announces Conference Call to Provide Business Update

May 14, 2015: PlasmaTech Biopharmaceuticals Announces Completion of Sanfilippo Syndrome (MPS IIIB) Toxicology Studies at American Society of Gene and Cell Therapy Annual Meeting

May 12, 2015: PlasmaTech Biopharmaceuticals Announces Appointment of Todd Wider, MD to Board of Directors

May 11, 2015: PlasmaTech Biopharmaceuticals Closes $10 Million Financing

May 6, 2015: PlasmaTech Biopharmaceuticals Announces Agreement to Acquire Abeona Therapeutics LLC

April 29, 2015: Understanding Radiation Proctitis: New Approach Addresses the Needs of Ovarian, Colon and Prostate Cancer Patients

April 24, 2015: PlasmaTech Biopharmaceuticals Announces Closing of Upsized $7 Million Private Placement

April 15, 2015: New Breakthroughs to Avoid Shortage of Treatment for Those With Inherited COPD

April 14, 2015: PlasmaTech Biopharmaceuticals Bolsters Scientific Advisory Board With Alpha-1 Expert Charlie Strange, M.D.

April 7, 2015: PlasmaTech Biopharmaceuticals Appoints Alpha-1 Expert Robert Sandhaus, MD, Ph.D. To Its Scientific Advisory Board

April 2, 2015: PlasmaTech Biopharmaceuticals' Announces $5 million private placement

April 1, 2015: PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements

March 31, 2015: PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea

March 10, 2015: PlasmaTech Biopharmaceuticals To Present at 27th Annual ROTH Capital Partners Conference - NEW TIME SLOT

March 5, 2015: PlasmaTech Biopharmaceuticals' Announces Initiation Of Enrollment Of MuGard® Trial For Afinitor® (Everolimus; Novartis) - Related Stomatitis At UCLA Breast Cancer Center

March 3, 2015: PlasmaTech Biopharmaceuticals To Present at 27th Annual ROTH Capital Partners Conference

February 9, 2015: PLASMATECH BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events

February 6, 2015: PlasmaTech Biopharmaceuticals To Present at 17th Annual BIO CEO & Investor Conference

January 14, 2015: PlasmaTech Biopharmaceuticals to Present at Biotech Showcase 2015

January 12, 2015: PlasmaTech Biopharmaceuticals To Present at OneMedForum Investor Conference in San Francisco

January 6, 2015: PLASMATECH BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events

January 5, 2015: PLASMATECH BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articl

Press Releases

Stay up to date with the latest news from Abeona Therapeutics.
Read Press Releases »

Events & Presentations

Watch past webcasts, listen to conference calls, and view a schedule of events.
View Materials »

Stock Information

Everything you need to know about Abeona’s stock history and analysis.
View Stock Information »

Financial Information

View all of Abeona’s SEC filings, quarterly reports, and other pertinent documents.
View Financial Information »

Corporate Governance

Learn about Abeona’s Board of Directors, Code of Ethics, and Governing Guidelines.
Learn More »

Contact Information

Get in touch about investments and business collaborations.
Contact Us »